DK1075476T3 - Hidtil ukendte benzimidazoler og benzoxazoler - Google Patents

Hidtil ukendte benzimidazoler og benzoxazoler

Info

Publication number
DK1075476T3
DK1075476T3 DK99920814T DK99920814T DK1075476T3 DK 1075476 T3 DK1075476 T3 DK 1075476T3 DK 99920814 T DK99920814 T DK 99920814T DK 99920814 T DK99920814 T DK 99920814T DK 1075476 T3 DK1075476 T3 DK 1075476T3
Authority
DK
Denmark
Prior art keywords
benzoxazoles
benzimidazoles
hitherto unknown
compounds
hitherto
Prior art date
Application number
DK99920814T
Other languages
English (en)
Inventor
Wolf-Ruediger Ulrich
Hermann Amschler
Beate Schmidt
Thomas Martin
Hildegard Boss
Dieter Flockerzi
Armin Hatzelmann
Rolf Beume
Ulrich Kilian
Hans-Peter Kley
Thomas Baer
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1075476T3 publication Critical patent/DK1075476T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99920814T 1998-05-05 1999-04-29 Hidtil ukendte benzimidazoler og benzoxazoler DK1075476T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98108125 1998-05-05
PCT/EP1999/002900 WO1999057115A1 (de) 1998-05-05 1999-04-29 Neue benzimidazole und -oxazole

Publications (1)

Publication Number Publication Date
DK1075476T3 true DK1075476T3 (da) 2003-09-29

Family

ID=8231881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99920814T DK1075476T3 (da) 1998-05-05 1999-04-29 Hidtil ukendte benzimidazoler og benzoxazoler

Country Status (18)

Country Link
US (1) US6294564B1 (da)
EP (1) EP1075476B1 (da)
JP (1) JP2002513791A (da)
AT (1) ATE242239T1 (da)
AU (1) AU758194C (da)
CA (1) CA2331037A1 (da)
CZ (1) CZ299285B6 (da)
DE (1) DE59905847D1 (da)
DK (1) DK1075476T3 (da)
EE (1) EE04641B1 (da)
ES (1) ES2201712T3 (da)
HU (1) HUP0101678A3 (da)
IL (1) IL139317A0 (da)
PL (1) PL198759B1 (da)
PT (1) PT1075476E (da)
SI (1) SI1075476T1 (da)
WO (1) WO1999057115A1 (da)
ZA (1) ZA200006251B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH632628B (de) * 1976-07-26 Ciba Geigy Ag Verfahren zur herstellung von benzofuranyl-benzimidazolen und deren verwendung als optische aufheller.
DE2853765A1 (de) * 1978-12-13 1980-06-26 Bayer Ag Verfahren zur herstellung von benzimidazolylbenzofuranen
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
DK0672031T3 (da) 1992-12-02 2003-06-10 Pfizer Catecholdiethere som selektive PDE IV-inhibitorer
US5814651A (en) 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
US5998428A (en) * 1995-05-31 1999-12-07 Smithkline Beecham Corporation Compounds and methods for treating PDE IV-related diseases
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
ES2152414T3 (es) 1994-07-22 2001-02-01 Byk Gulden Lomberg Chem Fab Dihidrobenzofuranos.
AU699489B2 (en) 1994-10-12 1998-12-03 Euro-Celtique S.A. Novel benzoxazoles
US5665737B1 (en) 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
JP2001503443A (ja) 1996-11-11 2001-03-13 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 新規イミダゾ―及びオキサゾロピリジン

Also Published As

Publication number Publication date
CZ299285B6 (cs) 2008-06-04
JP2002513791A (ja) 2002-05-14
SI1075476T1 (en) 2003-10-31
AU758194B2 (en) 2003-03-20
EP1075476A1 (de) 2001-02-14
DE59905847D1 (de) 2003-07-10
CZ20004095A3 (cs) 2001-04-11
ATE242239T1 (de) 2003-06-15
HUP0101678A3 (en) 2002-06-28
IL139317A0 (en) 2001-11-25
AU3825099A (en) 1999-11-23
ZA200006251B (en) 2002-02-27
PL198759B1 (pl) 2008-07-31
HUP0101678A2 (hu) 2002-05-29
EP1075476B1 (de) 2003-06-04
EE04641B1 (et) 2006-06-15
PT1075476E (pt) 2003-10-31
AU758194C (en) 2004-04-08
ES2201712T3 (es) 2004-03-16
CA2331037A1 (en) 1999-11-11
US6294564B1 (en) 2001-09-25
PL343848A1 (en) 2001-09-10
WO1999057115A1 (de) 1999-11-11
EE200000647A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
PT882021E (pt) Novas fenantridinas
EA200100731A1 (ru) Фенилфенантридины с ингибирующей фдэ-4 активностью
EE200000033A (et) Uudsed tetrasoolderivaadid
MX9700557A (es) Dihidrobenzofuranos.
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
ATE270278T1 (de) Phthalazinone pde iii/iv hemmer
DK0889886T3 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
ATE355284T1 (de) Inhibitoren von serinproteasen
PT937074E (pt) Benzonaftiridinas como terapeutica bronquica
DE69821530D1 (de) Dihydrobenzifurane
TR200002580T2 (tr) Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
ATE269313T1 (de) Tryptase-inhibitoren
DE60011300D1 (de) Inhibitoren der tryptase
AU758194C (en) Novel benzimidazoles and benzoxazoles
PT937075E (pt) Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese
DE50001742D1 (de) Arylsulfonamid-substituierte benzimidazolderivate und ihre verwendung als tryptase-inhibitoren